IO INFORMATICS EXTENDS ITS SCIENTIFIC ADVISORY BOARD WITH WELL-RECOGNIZED LUMINARIES IN HEALTHCARE AND LIFE SCIENCES
Appointment of Charles N. Mead, MD, MS and Mark A. Musen, MD, PhD to its SAB.
BERKELEY, CA; PALO ALTO, CA; PARIS, FRANCE - June 3, 2013
IO Informatics, the leading provider of semantic modeling and integration tools and services for Healthcare and Life Sciences, announced today that it has appointed Dr. Charles Mead and Dr. Mark Musen to its Scientific Advisory Board (SAB).
“All here at IO are extremely delighted to have such highly recognized thought leaders in Life Sciences informatics joining our SAB. Their life-time expertise and insights will further enrich the community of visionary and experienced professionals our SAB is comprised of. Having had the opportunity to work with both Charles and Mark during regular Worldwide Web Consortium (W3C) meetings and through numerous interactions at Stanford University’s National Center for Biomedical Ontologies (NCBO) among others, everyone is very excited about the combined vision and practical knowledge they will contribute to the group. They bring crucial expertise as Healthcare and Life Sciences transition towards sustainable, interoperable and outcome-oriented business models through the use of semantic technology,” Dr. Erich Gombocz, Chair of the SAB and Chief Science Officer at IO Informatics, remarks.
Dr. Mead added: “I am both honored and excited to be joining the IO Informatics SAB. By virtue of combined experience, talent, and offerings, I believe that IO is ideally positioned to become a major player in the emerging – and virtually inevitable – adoption of Semantic Web technologies as key components in integrating data across the Translational Medicine Continuum.”
Dr. Charles Mead is Director of Healthcare IT, Octo Consulting Group and CoChair, W3C Healthcare Life Sciences (HCLS) Working Group with over 35 years of experience in various aspects of healthcare informatics including standards development. He has also been involved in a venture-funded point-of-care system in home healthcare, large-scale enterprise service-oriented architecture development, and had a 3-year role as Director of the Graduate Program in Nursing Informatics at University of California, San Francisco. Working early-on in computable semantics leading the ambulatory electrocardiogram algorithm development and pattern recognition efforts at Washington University in St. Louis, he was for over 20 years active in several clinical standard organizations and served on the Board of Directors of CDISC and HL7. As Chair of the HL7 Architecture Board from 2008-13, he led the development of the ANSI standard Service-Oriented Interoperability Framework Canonical Definition (SAIF CD). During his time as CIO of the National Cancer Institute (NCI) he led the efforts at the caBIG initiative to accelerate Cancer research. As Co-Chair of the W3C Healthcare Life Sciences Work Group, his current work focuses on using Semantic Web tools and technologies to accelerate adoption of standards (metadata) for interoperability and data representation in translational medicine.
Dr. Musen is Professor of Medicine (Biomedical Informatics), Division Head (BMIR) and Co-Director of the Biomedical Informatics Training Program at Stanford University. His laboratory conducts research related to intelligent systems, the Semantic Web, reusable ontologies and knowledge representations, and biomedical decision support. His long-standing work on a system known as Protégé has led to an open-source technology now used by thousands of developers around the world to build intelligent computer systems and new computer applications for e-science and the Semantic Web. He is known for his research on the application of intelligent computer systems to assist health-care workers in guideline-directed therapy and in management of clinical trials. He is principal investigator of the National Center for Biomedical Ontology (NCBO), one of the seven National Centers for Biomedical Computing supported by the NIH Roadmap.
Dr. Mark Musen stated, “Semantic technology offers enormous opportunities to help make sense of data in both the life sciences and clinical medicine. IO Informatics has done a great job of helping its users to integrate and analyze data using semantic approaches. They have been great supporters of the National Center for Biomedical Ontology, and I am looking forward to helping them in their work to demonstrate the value of semantic technology in biomedicine."
IO Informatics’ SAB meets quarterly to provide input on the validity of new tools and technologies for academics, government and industry. Meet IO Informatics and SAB members at next week’s SemTech conference (http://semtechbizsf2013.semanticweb.com/) in San Francisco, where IO Informatics will give a talk.
ABOUT IO INFORMATICS
IO is at the forefront of the semantic technology wave. The Company provides software and services for uniquely efficient data integration and transformative knowledge applications in life sciences, biotechnology, pharmaceutical, and medical environments.
For more information visit: http://www.io-informatics.com
Robert A. Stanley
President and CEO, IO Informatics, Inc.